Fulcrum Therapeutics to Attend September Conferences

CAMBRIDGE, Mass., Aug. 27, 2024 -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a biopharmaceutical company at the clinical stage, has announced its management's participation in a series of forthcoming investor meetings. These meetings will be held at two significant conferences: the Wells Fargo Healthcare Conference, scheduled for Wednesday, September 4, 2024, in Boston, MA, and the Morgan Stanley 22nd Annual Global Healthcare Conference, taking place on Friday, September 6, 2024, in New York, NY.

Fulcrum Therapeutics specializes in the development of small molecules aimed at improving the quality of life for patients suffering from genetically defined rare diseases. The company is particularly focused on areas with high unmet medical needs. Currently, Fulcrum has two leading programs in clinical development. The first is losmapimod, a small molecule under investigation for the treatment of facioscapulohumeral muscular dystrophy (FSHD). The second is pociredir, another small molecule aimed at increasing the expression of fetal hemoglobin, which is being developed for the treatment of sickle cell disease (SCD).

The company's unique approach involves the use of proprietary technology to identify drug targets capable of modulating gene expression. This targeted approach aims to address the fundamental causes of gene mis-expression, thereby treating the underlying issues of these genetic diseases. 

Fulcrum Therapeutics continues to work on expanding its portfolio and advancing its clinical programs. The upcoming investor meetings are a testament to the company's commitment to transparency and engagement with the investment community. These events provide an opportunity for stakeholders to gain deeper insights into Fulcrum's ongoing projects and future plans. 

How to obtain the latest research advancements in the field of biopharmaceuticals?

In the Synapse database, you can keep abreast of the latest research and development advances in drugs, targets, indications, organizations, etc., anywhere and anytime, on a daily or weekly basis. Click on the image below to embark on a brand new journey of drug discovery!